*An off-label use of a medication is a use that is not FDA-approved
Back to Journals Drug Design, Development and Therapy Volume 16 The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases Authors Cheng D, Yang S, Zhao X, Wang G Received 5 November 2021 Accepted for publication 18 February 2022 Published 14 March 2022 Volume 2022:16 Pages 665684 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Tuo Deng Dihe Cheng, Shuo Yang, Xue Zhao, Guixia Wang Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, Peoples Republic of China Correspondence: Guixia Wang
Noticeable improvement from week 1
Linda Brown from Seattle, was on the brink of death due to severe obesity, but our latest product saved her life
"It depends on the individual